Literature DB >> 20397132

Development of a Hodgkin disease tumor in the neck of a patient who previously had undergone complete excision of a hyaline-vascular Castleman disease neck mass.

Evrim E Unsal Tuna1, Cem Ozbek, Nilüfer Arda, Evrensel Ilkdogan, Hüseyin Dere, Cafer Ozdem.   

Abstract

Castleman disease is an uncommon cause of a neck mass. A benign lymphoproliferative disorder, it may be seen as a self-limited unicentric process or as a fulminant multicentric disease with systemic symptoms. The association between Hodgkin disease and Castleman disease has been debated extensively, but this association is rare. The associated Hodgkin disease frequently has been of the interfollicular subtype and typically has coexisted with the multicentric plasma-cell variant of Castleman disease. We report a case of mixed-cellularity Hodgkin disease of the neck in a patient previously diagnosed with hyaline-vascular-type Castleman disease who had undergone complete excision of a neck mass 2 years earlier.

Entities:  

Mesh:

Year:  2010        PMID: 20397132

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  Localized Castleman's disease in the breast.

Authors:  René Aloísio da Costa Vieira; Jorge Shigueo Kunizaki; Abaeté Leite do Canto; Adriano Diniz Baptista Mendes; José Spartaco Vial; Angelo Gustavo Zucca Matthes; Anapaula Uema Watanabe; Cristovam Scapulatempo Neto
Journal:  Int J Surg Case Rep       Date:  2013-01-19

Review 2.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

3.  Castleman's disease mimicking lymph node metastases in a young woman with laryngeal cancer.

Authors:  Krystyna Serkies; Małgorzata Łazar-Poniatowska; Joanna Seredyńska; Wojciech Biernat; Jacek Jassem
Journal:  Contemp Oncol (Pozn)       Date:  2016-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.